Vanderbilt Univeristy Ingram Cancer Ctr. — Nashville, Tennessee

Vanderbilt Univeristy Ingram Cancer Ctr. is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Univeristy Ingram Cancer Ctr. has participated in 1 clinical trials.

Therapeutic areas: Gastrointestinal Stromal Tumor (GIST).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Univeristy Ingram Cancer Ctr.?

Vanderbilt Univeristy Ingram Cancer Ctr. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Univeristy Ingram Cancer Ctr. conducted?

Vanderbilt Univeristy Ingram Cancer Ctr. has 1 clinical trials on record. Their work covers Gastrointestinal Stromal Tumor (GIST).

Is Vanderbilt Univeristy Ingram Cancer Ctr. accredited by Crixeo Health?

Vanderbilt Univeristy Ingram Cancer Ctr. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Univeristy Ingram Cancer Ctr.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.